Prostate cancer is the most common type of cancer in men. This type of cancer often develops slowly and has a low mortality rate, but it can also present in more aggressive forms. It is unclear which genetic abnormalities influence the progression of prostate cancer. A fusion of two genes (TMPRSS2:ERG) are detected in half of all prostate cancers. Using a cell culture model in which TMPRSS2:ERG is expressed under antibiotic control, this dissertation examined the molecular changes caused by this gene fusion. Our results reveal that this fusion is paired with aggressive changes in the prostate cancer cell. With these findings, we hope to contribute to improved risk assessment and new treatment methods for prostate cancer patients.
|Award date||15 Dec 2017|
|Place of Publication||Maastricht|
|Publication status||Published - 2017|
- aggressive prostate cancer
- gene fusion